Sridic-AQ 75mg Injection
By Sridic-AQ
Rx
1ml Injection in a Vial

Composition
Diclofenac(75mg)

Manufacturer - Sarian Healthcare
D-901, SIGNATURE-2 NR. SARKHEJ-SANAND CIRCLE, SARKHEJ, AHMEDABAD-382210

Expires on or after
November, 2025

liver
Caution for Liver - When using Sridic-AQ 75mg Injection, it's important to be cautious if you have liver disease. Your doctor may need to adjust the dosage accordingly. It's advisable to consult your doctor before taking this medicine if you have liver issues. If you are advised to use Sridic-AQ 75mg Injection for an extended period, regular monitoring of liver function tests is recommended especially in patients with liver disease.

kidney
Sridic-AQ 75mg Injection should be used carefully in patients with kidney disease. It may require a dose adjustment. Consult your doctor.

alcohol
When taking Sridic-AQ 75mg Injection, it is important to be cautious about consuming alcohol. It is recommended to consult your doctor for guidance.

driving
Caution while driving Sridic-AQ 75mg Injection may cause headaches, blurred vision, dizziness, or drowsiness in some patients, affecting the ability to drive.

pregnancy
Sridic-AQ 75mg Injection may pose risks to the developing baby during pregnancy. However, in rare life-threatening cases, a doctor may consider its use if benefits outweigh risks. Consult a doctor before use.

breastfeeding
Sridic-AQ 75mg Injection is considered safe for breastfeeding based on limited human data indicating no significant risk to the baby.
Habit Forming | No |
Chemical Class | Phenylacetic acid Derivative |
Therapeutic Class | PAIN ANALGESICS |
Action Class | NSAID's- Non-Selective COX 1&2 Inhibitors (acetic acid) |
₹15
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 18-Nov-2024